China SXT Pharmaceuticals

NASDAQ: SXTC
Nasdaq Stock Market
Healthcare Drug Manufacturers - Specialty & Generic
Global Rank
#33278
Country Rank
#6180
Market Cap
29.81 M
Price
1.86
Change (%)
7.51%
Volume
111,007

China SXT Pharmaceuticals (NASDAQ: SXTC) Stock Split History

Date Split Ratio Multiple Cumulative multiple Type
02/25/2025 1:8 x0.125 x0.0000625 Reverse
10/05/2023 1:25 x0.04 x0.0005 Reverse
05/19/2022 1:20 x0.05 x0.0125 Reverse
02/22/2021 1:4 x0.25 x0.25 Reverse

Frequently Asked Questions

  • How much would China SXT Pharmaceuticals stock be worth if it never split?
    If China SXT Pharmaceuticals (stock symbol: NASDAQ: SXTC) had never undergone any stock splits, its price per share today would be approximately 0.00 USD. This calculation reflects the cumulative effect of all splits, including the most recent split (ratio: 1-for-8) that occurred on 02/25/2025.
  • China SXT Pharmaceuticals (stock symbol: NASDAQ: SXTC) has undergone a total of four stock splits. The most recent split occurred on 02/25/2025. One share bought prior to the first split on 02/22/2021 would now equal 0.00 shares.
  • China SXT Pharmaceuticals (stock symbol: NASDAQ: SXTC) has undergone four stock splits in its history. The most recent split, a 1-for-4 split, occurred on 02/25/2025. While future splits are not guaranteed, significant increases in stock price could prompt consideration for another split.

MarketCapWatch.com ranks all listed companies worldwide, providing unique insights into market capitalization across industries. As one of the most comprehensive ranking platforms, it covers companies of all sizes and sectors.

Ranking

Copyright © 2025. All rights reserved

Important Disclaimer: All content provided on this website, including hyperlinked pages, related applications, forums, blogs, social media accounts, and other platforms ("the Site"), is for general informational purposes only and sourced from third-party providers. We make no guarantees regarding the accuracy, completeness, or timeliness of the content.

None of the information presented constitutes financial, legal, or professional advice. Users should conduct their own research, evaluation, and verification before making any decisions. Investing and trading carry significant risks that may lead to substantial losses. Therefore, we strongly recommend consulting a qualified financial advisor before taking any action.